For Immediate Release


Yvonne M. Psaila

Director, Marketing & Communications

Keystone Symposia on Molecular & Cellular Biology

+ 1 970-262-2676



Keystone Symposia to Host Virtual ePanel on Reproducibility in Biomedical Research November 8, 2017


SILVERTHORNE, CO – October 12, 2017 – Keystone Symposia is pleased to announce that it will host an ePanel discussion on the important and timely topic of “Rigor in Science: The Challenge of Reproducibility in Biomedical Research” on November 8, 2017 at 2:30 PM ET. The free 90-minute event will be broadcast globally and will include a 30-minute audience Q&A session. The event is open to everyone; online registration is required at Audience members can enter a question for the panel either when they register or during the event broadcast via the chat room.


The panel will be moderated by journalist Richard Harris of NPR, who recently published a book entitled Rigor Mortis on the topic. Panelists include Drs. Michael Holtzman and Jeffrey Haspell of Washington University School of Medicine, Dana Philpott of the University of Toronto, and Patricia Valdez of the National Institutes of Health. Joining for the live Q&A will be Dr. Michael Lauer of the National Institues of Health, as well as Alison Farrell, Senior Editor at Nature Medicine, and Emilie Marcus, CEO of Cell Press, to provide a perspective from the publishing world and discuss new standards journals are adopting for the articles they accept for publication.


Scientists are increasingly finding that factors like age and sex as well as environmental factors such as temperature, different microbiota, time of day/circadian rhythms and even the sex of animal handlers are influencing the outcome of their experiments and causing difficultly in reproducing their results. According to Dr. Michael Holtzman who helped to plan the event, “Some non-reproducible experimental results are due to lack of attention to key controls or methods, and in rare cases are based on data manipulation, but most of the difficulties come from failing to recognize important biological variables. This conversation aims at transparency and accountability in biomedical research mainly by addressing the biological basis for data discrepancies, and should be of interest to researchers and non-researchers interested in the challenging process of scientific discovery.”



About Virtual Keystone Symposia


Keystone Symposia’s new “Virtual Keystone Symposia” format is a way to hold short symposia and panel discussions on timely topics that can benefit from an accelerated production schedule. The format also serves as a way to share the scientific insights gained with a more extensive global audience than those who can attend face-to-face conferences. To date since this new programming model was launched about four years ago, more than 6,000 people have participated in Virtual Keystone Symposia events, which have been held on diverse topics including neuroscience, genome editing, noncoding RNAs, malaria, HIV antibodies and multiple sclerosis. All events are available to view in archived form at In addition to virtual events, this site also houses a number of scientific video talks filmed at various Keystone Symposia conferences.




About Keystone Symposia on Molecular and Cellular Biology


Keystone Symposia on Molecular and Cellular Biology, a 501(c)(3) nonprofit organization, has been conducting internationally renowned, open scientific conferences since its founding as UCLA Symposia in 1972 and has been headquartered in Summit County, Colorado, USA since 1990.


It will convene 60 face-to-face conferences in the 2017-2018 season, the majority of which will take place between January and April 2018, on topics ranging from cancer and immunology to neuroscience and genomics. Registration fees are supplemented by generous financial support from corporate, foundation and individual donors as well as government grants.


More information about the organization and its meetings is located at and, respectively.